| Jul 31 |
ALX Oncology to Host Investor Call and Webcast to Share Topline Data Results From ASPEN-06 Phase 2 Clinical Trial of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer
|
| Jul 9 |
IDEAYA (IDYA) Up on Upbeat Phase II Bladder & Lung Cancer Data
|
| Jul 9 |
Adicet (ACET) Up as Kidney Cancer Drug Gets FDA's Fast Track Tag
|
| Jul 8 |
Dianthus (DNTH) Gains 18% in the Past Month: Here's Why
|
| Jul 5 |
Roche (RHHBY) Receives FDA Nod for Vabysmo Prefilled Syringe
|
| Jul 4 |
Roche's (RHHBY) Combo Therapy Misses Lung Cancer Study Goals
|
| Jul 3 |
Cartesian (RNAC) MG Study Meets Goals, Stock Down on Other Updates
|
| Jul 3 |
Annovis (ANVS) Up as Its Lead Candidate Meets Goals in PD Study
|
| Jul 2 |
Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag
|
| Jul 1 |
Apellis (APLS) Falls on Second Negative CHMP Opinion for GA Drug
|
